BAG3 and neoplasm: In a short communication article, Lorio et al. reported that blocking anti-Bcl-2-Associated athanoGene 3 (BAG3) with an antibody resulted in an increased number of CD8+ T cell infiltration to the tumor site in a PDAC mouse model.